Mike holds BA, MS, and Ph.D. degrees in Analytical Chemistry and Biotechnology. He
has nearly 3 decades of experience in the consumer healthcare industry in various
roles of increasing responsibility with some of the world’s leading companies, including
GlaxoSmithKline and Pfizer. Mike has broad-based knowledge of consumer healthcare
and currently serves as Chief Science Officer and Board Member at Young Living Essential
Oils, a rapidly growing multi-billion dollar international wellness company and the
largest provider of essential oils in the world. He is directly responsible for leading
Research, Development, Product Management, and Quality Assurance across Young Living.
Dr. Buch has expertise in leading global strategic development programs, open innovation
programs, licensing programs, consumer healthcare R&D, advanced technologies labs,
advanced optical analysis labs, and biosensor design and research. His work has directly
led to the development of consumer healthcare products with annual sales exceeding
$3 billion and his products have been marketed in more than 100 countries. His success
has resulted in more than a dozen patents in the health care field, several books,
and a numerous published articles in peer-reviewed scientific journals. Dr. Buch is
also a member of several prestigious associations, including the American Chemical
Society, the American Association for the Advancement of Science, and he was recently
installed as a member of the board of directors for the Institute on Science for Global
Policy.
